Researchers from the University of Illinois Urbana-Champaign and Northwestern University have developed and tested a new mathematical model to accurately simulate the effects of blood flow on the adhesion and retention of nanoparticle drug carriers. The model closely corresponded to in vitro experiments, demonstrating the impact that model-based simulations can have on nanocarrier optimization. “There have been studies using mouse models and in vitro tissue models,” said Hyunjoon Kong, one of the researchers involved in this study. “However, we have been designing nanoparticles mostly by trial and error. This is the first kind of demonstration where there is a more systematic, robust design of nanoparticles, under the guidance of physics.”
An official website of the United States government.